Rapid, Antibody-Free Detection of Recombinant Proteins on Blots Using Enzyme Fragment Complementation

  • Neil W. CharterEmail author
  • Joe Horecka
  • Chin-Yee Loh
  • Albert Doan
  • Tom Wehrman
  • Keith R. Olson
Part of the Methods in Molecular Biology book series (MIMB, volume 1314)


Alternative, antibody-free techniques to western analysis of protein blots can offer reduced assay times for routine analysis of expression of recombinant proteins. We have adapted the commercially available enzyme fragment complementation technology to provide a rapid protein detection method for protein blots based on significantly reducing the number of incubation and washing steps used in traditional approaches, and eliminating the requirement for antibodies. In this chapter, we highlight the use of this assay for measuring recombinant protein expressed in mammalian cells for a range of applications, including dot blot screening of large numbers of different cell samples, assessment of protein integrity through detection of degradation bands, and characterization of posttranslational protein modifications such as glycosylation.

Key words

Protein blot Recombinant protein Enzyme fragment complementation Chemiluminescent detection 


  1. 1.
    Kurien BT, Scofield RH (2003) Protein blotting: a review. J Immunol Methods 274:1–15PubMedCrossRefGoogle Scholar
  2. 2.
    McIlhinney RA (2004) Generation and use of epitope-tagged receptors. Methods Mol Biol 259:81–98PubMedGoogle Scholar
  3. 3.
    Patton WF (2002) Detection technologies in proteome analysis. J Chromatogr B Analyt Technol Biomed Life Sci 771:3–31PubMedCrossRefGoogle Scholar
  4. 4.
    Langley KE, Villarejo MR, Fowler AV, Zamenhof PJ, Zabin I (1975) Molecular basis of beta-galactosidase alpha-complementation. Proc Natl Acad Sci U S A 72:1254–1257PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Eglen RM (2002) Enzyme fragment complementation: a flexible high throughput screening assay technology. Assay Drug Dev Technol 1:97–104PubMedCrossRefGoogle Scholar
  6. 6.
    Zhao X, Vainshtein I, Gellibolian R, Shu Y, Dotimas H, Wang XM et al (2003) Homogeneous assays for cellular protein degradation using beta-galactosidase complementation: NF-kappaB/IkappaB pathway signaling. Assay Drug Dev Technol 1:823–833PubMedCrossRefGoogle Scholar
  7. 7.
    Vainshtein I, Silveria S, Kaul P, Rouhani R, Eglen RM, Wang J (2002) A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP). J Biomol Screen 7:507–514PubMedCrossRefGoogle Scholar
  8. 8.
    Naqvi T, Lim A, Rouhani R, Singh R, Eglen RM (2004) Beta galactosidase enzyme fragment complementation as a high-throughput screening protease technology. J Biomol Screen 9:398–408PubMedCrossRefGoogle Scholar
  9. 9.
    Horecka J, Charter NW, Bosano BL, Fung P, Kobel P, Peng P et al (2006) An antibody-free method for protein detection on blots using enzyme fragment complementation. Biotechniques 40:381–383PubMedCrossRefGoogle Scholar
  10. 10.
    Macian F (2005) NFAT proteins: key regulators of T-cell development and function. Nat Rev Immunol 5:472–484PubMedCrossRefGoogle Scholar
  11. 11.
    Horsley V, Pavlath GK (2002) NFAT: ubiquitous regulator of cell differentiation and adaptation. J Cell Biol 156:771–774PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2015

Authors and Affiliations

  • Neil W. Charter
    • 1
    Email author
  • Joe Horecka
    • 2
  • Chin-Yee Loh
    • 1
  • Albert Doan
    • 1
  • Tom Wehrman
    • 1
  • Keith R. Olson
    • 1
  1. 1.DiscoveRx CorporationFremontUSA
  2. 2.Stanford Genome Technology CenterStanfordUSA

Personalised recommendations